Liver diseases such as cirrhosis and liver cancer are killing hundreds of people each day across the WHO European region, according to a commentary published in The Lancet. The second European Association for the Study of the Liver (EASL)–Lancet Commission on liver health in Europe arrives at a critical juncture for public health.
This burden is often misunderstood as a niche clinical concern, the authors argue, when in fact it forms a significant and neglected component of the region's non-communicable disease (NCD) crisis. The commission builds upon recommendations from the first EASL–Lancet report published in 2021.